Results
1 -
10 of
111Rasagiline Promotes Regeneration of Substantia Nigra Dopaminergic Neurons in Post-MPTP-induced Parkinsonism via Activation of Tyrosine Kinase Receptor Signaling Pathway, Neurochemical Research New Antiparkinsonian Agents Target Unmet Therapeutic Needs, Pharmaceutical & Diagnostic Innovation Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection, Oxidative Stress and Neuroprotection Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders, MAO u2014 The Mother of all Amine Oxidases Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey, MAO u2014 The Mother of all Amine Oxidases Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022, Advances in Research on Neurodegeneration Molecular Basis of Neuroprotective Activities of Rasagiline and the Anti-Alzheimer Drug TV3326 [lpar;N-Propargyl-(3R) Aminoindan-5-YL)-Ethyl Methyl Carbamate], Cellular and Molecular Neurobiology Pharmacology and neuroprotective properties of rasagiline, Deprenyl u2014 Past and Future